Altimmune, Inc. (ALT) vs ProKidney Corp. (PROK)
- Altimmune, Inc. ALT 2.46 −3.91%
- ProKidney Corp. PROK 1.56 −6.59%
Altimmune, Inc. and ProKidney Corp. are both Biotechnology companies. Altimmune, Inc. and ProKidney Corp. are of similar size ($526.0M and $507.7M). Altimmune, Inc. has the higher net margin (0.00% vs −10,288.4%) and the lower return on invested capital (−34.3% vs 0.00%). Across the 14 metrics below, Altimmune, Inc. leads on 8 and ProKidney Corp. on 6.
Valuation
Profitability
| Metric | ALT | PROK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (21,664.55%) | 0.00% |
| Net margin | 0.00% | (10,288.39%) | 0.00% |
| Free cash flow margin | 0.00% | (17,300.61%) | 0.00% |
| Return on equity | (28.87%) | 8.92% | (56.66%) |
| Return on assets | (25.58%) | (27.10%) | (49.22%) |
| Return on invested capital | (34.30%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack